Insider Selling: NeueHealth (NYSE:NEUE) Director Sells 4,195 Shares of Stock

NeueHealth, Inc. (NYSE:NEUE) Director Anthony Jr. Florence sold 4,195 shares of NeueHealth stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $6.75, for a total transaction of $28,316.25. Following the completion of the transaction, the director owned 488,702 shares of the company’s stock, valued at $3,298,738.50. This represents a 0.85% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

NeueHealth Stock Performance

Shares of NYSE:NEUE opened at $6.75 on Tuesday. NeueHealth, Inc. has a 52 week low of $3.79 and a 52 week high of $7.66. The company’s 50 day moving average is $6.72 and its two-hundred day moving average is $6.73. The company has a market cap of $60.94 million, a PE ratio of -0.42 and a beta of 0.59.

NeueHealth (NYSE:NEUE) last issued its earnings results on Thursday, August 7th. The company reported ($1.68) EPS for the quarter, topping analysts’ consensus estimates of ($4.77) by $3.09. The firm had revenue of $209.08 million for the quarter, compared to analyst estimates of $249.50 million. As a group, equities research analysts expect that NeueHealth, Inc. will post -9.13 EPS for the current year.

Hedge Funds Weigh In On NeueHealth

A hedge fund recently bought a new stake in NeueHealth stock. PenderFund Capital Management Ltd. bought a new stake in NeueHealth, Inc. (NYSE:NEUE) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 29,115 shares of the company’s stock, valued at approximately $197,000. PenderFund Capital Management Ltd. owned about 0.33% of NeueHealth as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 63.88% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of NeueHealth in a report on Saturday, September 27th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and an average price target of $7.00.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.